Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a

FASEB Journal

Volumn 29, Issue 8, 2015, Pages 3436-3445

  Wang, Shuxia ^a,b   Song, Kangxing ^a,b   Srivastava, Roshni ^a   Dong, Chao ^a   Go, Gwang Woong ^a   Li, Na ^c   Iwakiri, Yasuko ^a   Mam, Arya ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Kookmin University   (South Korea)

Author keywords

Hepatic steatosis; LRP6; PKC; RhoA; ROCK

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN; WNT PROTEIN; WNT3A PROTEIN; ACTIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE D; RHO KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; FATTY LIVER; LIVER; LIVER CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

MUS;

ACTINS; ANIMALS; CELL LINE, TUMOR; CELL TRANSDIFFERENTIATION; FATTY LIVER; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIVER; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 84940108581     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-271171     Document Type: Article

References (37)

1. Cohen, J. C., Horton, J. D., and Hobbs, H. H. (2011) Human fatty liver disease: old questions and new insights. Science 332, 1519-1523
2. Yki-Järvinen, H. (2014) Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2, 901-910
3. Hebbard, L., and George, J. (2011) Animal models of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 8, 35-44
4. Zeb, I., Katz, R., Nasir, K., Ding, J., Rezaeian, P., and Budoff, M. J. (2013) Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis. J. Cardiovasc. Comput. Tomogr. 7, 311-318
5. Kim, N. H., Park, J., Kim, S. H., Kim, Y. H., Kim, D. H., Cho, G. Y., Baik, I., Lim, H. E., Kim, E. J., Na, J. O., Lee, J. B., Lee, S. K., and Shin, C. (2014) Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart 100, 938-943
6. Idilman, I. S., Akata, D., Hazirolan, T., Doganay Erdogan, B., Aytemir, K., and Karcaaltincaba, M. (2015) Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study. J. Diabetes 7, 279-286
7. Mani, A., Radhakrishnan, J., Wang, H., Mani, A., Mani, M. A., Nelson-Williams, C., Carew, K. S., Mane, S., Najmabadi, H., Wu, D., and Lifton, R. P. (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315, 1278-1282
8. Singh, R., Smith, E., Fathzadeh, M., Liu, W., Go, G. W., Subrahmanyan, L., Faramarzi, S., McKenna, W., and Mani, A. (2013) Rare nonconservative LRP6 mutations are associated with metabolic syndrome. Hum. Mutat. 34, 1221-1225
9. Go, G. W., Srivastava, R., Hernandez-Ono, A., Gang, G., Smith, S. B., Booth, C. J., Ginsberg, H. N., and Mani, A. (2014) The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. Cell Metab. 19, 209-220
10. Huang, Y., Cohen, J. C., and Hobbs, H. H. (2011) Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J. Biol. Chem. 286, 37085-37093
11. Rotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E., and Liang, T. J.; NASH CRN. (2010) The association of genetic variability in patatinlike phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 52, 894-903
12. Bryja, V., Andersson, E. R., Schambony, A., Esner, M., Bryjová, L., Biris, K. K., Hall, A. C., Kraft, B., Cajanek, L., Yamaguchi, T. P., Buckingham, M., and Arenas, E. (2009) The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo. Mol. Biol. Cell 20, 924-936
13. Schulte, D. M., Müller, N., Neumann, K., Oberhäuser, F., Faust, M., Güdelhöfer, H., Brandt, B., Krone, W., and Laudes, M. (2012) Proinflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulatedby nutritional factorsin obese human subjects. PLoS One 7, e32437
14. Lu, H., Wu, J. Y., Kudo, T., Ohno, T., Graham, D. Y., and Yamaoka, Y. (2005) Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol. Biol. Cell 16, 4954-4966
15. Lo Grasso, P. V., and Feng, Y. (2009) Rho kinase (ROCK) inhibitors and their application to inflammatory disorders. Curr. Top. Med. Chem. 9, 704-723
16. Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A., and Walsh, K. (2010) Sfrp5 is an antiinflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454-457
17. Singh, R., De Aguiar, R. B., Naik, S., Mani, S., Ostadsharif, K., Wencker, D., Sotoudeh, M., Malekzadeh, R., Sherwin, R. S., and Mani, A. (2013) LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans. Cell Metab. 17, 197-209
18. Kim, J., Kim, J., Kim, D. W., Ha, Y., Ihm, M. H., Kim, H., Song, K., and Lee, I. (2010) Wnt5a induces endothelial inflammation via betacatenin-independent signaling. J. Immunol. 185, 1274-1282
19. Watsky, M. A., Weber, K. T., Sun, Y., and Postlethwaite, A. (2010) New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies. Int. Rev. Cell Mol. Biol. 282, 165-192
20. Eyden, B. (2008) The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J. Cell. Mol. Med. 12, 22-37
21. Morishima, Y., Nomura, A., Uchida, Y., Noguchi, Y., Sakamoto, T., Ishii, Y., Goto, Y., Masuyama, K., Zhang, M. J., Hirano, K., Mochizuki, M., Ohtsuka, M., and Sekizawa, K. (2001) Triggering theinductionof myofibroblast and fibrogenesis by airway epithelial shedding. Am. J. Respir. Cell Mol. Biol. 24, 1-11
22. Lemoinne, S., Cadoret, A., El Mourabit, H., Thabut, D., and Housset, C. (2013) Origins and functions of liver myofibroblasts. Biochim. Biophys. Acta 1832, 948-954
23. Ha, H., Yu, M. R., and Lee, H. B. (2001) High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int. 59, 463-470
24. Gressner, A. M., Weiskirchen, R., Breitkopf, K., and Dooley, S. (2002) Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7, d793-d807
25. Taura, K., Miura, K., Iwaisako, K., Osterreicher, C. H., Kodama, Y., Penz-Osterreicher, M., and Brenner, D. A. (2010) Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51, 1027-1036
26. Rygiel, K. A., Robertson, H., Marshall, H. L., Pekalski, M., Zhao, L., Booth, T. A., Jones, D. E., Burt, A. D., and Kirby, J. A. (2008) Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab. Invest. 88, 112-123
27. Schaale, K., Neumann, J., Schneider, D., Ehlers, S., and Reiling, N. (2011) Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses. Eur. J. Cell Biol. 90, 553-559
28. Tickenbrock, L., Schwäble, J., Strey, A., Sargin, B., Hehn, S., Baas, M., Choudhary, C., Gerke, V., Berdel, W. E., Müller-Tidow, C., and Serve, H. (2006) Wnt signaling regulates transendothelial migration of monocytes. J. Leukoc. Biol. 79, 1306-1313
29. Argo, C. K., Northup, P. G., Al-Osaimi, A. M., and Caldwell, S. H. (2009) Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J. Hepatol. 51, 371-379
30. Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L., and MacDougald, O. A. (2000) Inhibition of adipogenesis by Wnt signaling. Science 289, 950-953
31. Gunaratnam, K., Vidal, C., Gimble, J. M., and Duque, G. (2014) Mechanisms of palmitate-induced lipotoxicity in human osteoblasts. Endocrinology 155, 108-116
32. Neuschwander-Tetri, B. A. (2010) Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52, 774-788
33. Kumawat, K., Menzen, M. H., Bos, I. S., Baarsma, H. A., Borger, P., Roth, M., Tamm, M., Halayko, A. J., Simoons, M., Prins, A., Postma, D. S., Schmidt, M., and Gosens, R. (2013) Noncanonical WNT-5A signaling regulates TGF-%beta;-induced extracellular matrix production by airway smooth muscle cells. FASEB J. 27, 1631-1643
34. Chu, A. S., Diaz, R., Hui, J. J., Yanger, K., Zong, Y., Alpini, G., Stanger, B. Z., and Wells, R. G. (2011) Lineage tracing demonstrates no evidence of cholangiocyte epithelial-tomesenchymal transition in murine models of hepatic fibrosis. Hepatology 53, 1685-1695
35. Österreicher, C. H., Penz-Österreicher, M., Grivennikov, S. I., Guma, M., Koltsova, E. K., Datz, C., Sasik, R., Hardiman, G., Karin, M., and Brenner, D. A. (2011) Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc. Natl. Acad. Sci. USA 108, 308-313
36. Jung, Y., Witek, R. P., Syn, W. K., Choi, S. S., Omenetti, A., Premont, R., Guy, C. D., and Diehl, A. M. (2010) Signals from dying hepatocytes trigger growth of liver progenitors. Gut 59, 655-665
37. Patsenker, E., Popov, Y., Stickel, F., Jonczyk, A., Goodman, S. L., and Schuppan, D. (2008) Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology 135, 660-670